AWM Investment Company’s Clearside Biomedical CLSD Stock Holding History

AWM Investment Company’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-58,342	Closed	-$5.38M	–	87
2018 Q3	$5.38M	Buy	58,342 +14,009	+32%	+$1.67M	0.89%	43
2018 Q2	$7.11M	Buy	44,333 +6,989	+19%	+$1.18M	1.19%	32
2018 Q1	$6.01M	Buy	37,344 +30,011	+409%	+$3.66M	1.16%	28
2017 Q4	$770K	Buy	7,333 +518	+8%	+$55.6K	0.15%	85
2017 Q3	$893K	Sell	6,815 -19,947	-75%	-$2.44M	0.16%	76
2017 Q2	$3.66M	Buy	26,762 +4,014	+18%	+$482K	0.65%	41
2017 Q1	$2.71M	Buy	22,748 +14,415	+173%	+$1.7M	0.51%	55
2016 Q4	$1.12M	Buy	8,333 +5,000	+150%	+$1.26M	0.22%	78
2016 Q3	$867K	Hold	3,333	–	–	0.16%	84
2016 Q2	$350K	Buy	+3,333	New	+$349K	0.07%	87

Other funds holding CLSD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWM Investment Company's CLSD Position: Q4 2018 in Review

AWM Investment Company sold out of Clearside Biomedical (CLSD) in Q4 2018, closing a stake of 58,342 shares — an estimated $5.38M sold.

AWM Investment Company first reported a position in CLSD in Q2 2016 and held it in 10 quarters. The position peaked at $7.11M in Q2 2018. 69 funds tracked by Wall St. Rank hold CLSD as of Q4 2018.

AWM Investment Company reported no remaining Clearside Biomedical position as of Q4 2018 after selling out during the quarter.
AWM Investment Company sold 58,342 Clearside Biomedical shares in Q4 2018, an estimated $5.38M.
AWM Investment Company first reported a position in Clearside Biomedical in Q2 2016 and held it in 10 quarters.
AWM Investment Company's Clearside Biomedical position peaked at $7.11M in Q2 2018.
69 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2018.

Based on AWM Investment Company's 13F filing for Q4 2018, filed 13 Feb 2019.